ADASUVE (loxapine) inhalation powder is a prescription medication used for the rapid control of mild to moderate agitation in adults with schizophrenia or bipolar I disorder. It is administered through inhalation, allowing the medication to work quickly by delivering loxapine directly to the lungs and then into the bloodstream. ADASUVE is unique because it is the first and only inhalable therapy for the treatment of agitation associated with these psychiatric conditions. It is designed for use in a hospital or clinic setting under the supervision of a healthcare professional, due to the risk of bronchospasm that has been associated with its use. Patients are monitored after administration to ensure their safety and to manage any potential side effects.